TransCode Therapeutics Reports Second Quarter 2022 Results; Provides Business Update

Go back to TransCode Therapeutics Reports Second Quarter 2022 Results; Provides Business Update
(NASDAQ: RNAZ) Delayed: 1.64 -0.05 (2.96%)
Previous Close $1.69    52 Week High
Open $1.68    52 Week Low
Day High $1.68    P/E N/A 
Day Low $1.64    EPS
Volume 661